(Q37667639)

21 August 2017

1 reference

title

Anabolic steroid abuse and dependence in clinical practice (English)

1 reference

21 August 2017

1 reference

Kirk J Brower

1

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

The Physician and Sportsmedicine

21 August 2017

published in

1 reference

21 August 2017

volume

37

1 reference

21 August 2017

issue

4

1 reference

21 August 2017

page(s)

131-140

1 reference

Anabolic steroids: dependence and complications of chronic use.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Pharmacoepidemiology of anabolic androgenic steroids: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Use of doping agents, particularly anabolic steroids, in sports and society

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Pharmacology of anabolic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Side effects of anabolic androgenic steroids abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Current concepts in anabolic-androgenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Anabolic-androgenic steroid use in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Use of clomiphene citrate to reverse premature andropause secondary to steroid abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Psychological treatment of anabolic-androgenic steroid-dependent individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Anabolic steroid abuse and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Treating Steroid Abuse: A Psychiatric Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Anabolic-androgenic steroid abuse by physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Anabolic steroid users' attitudes towards physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Licit steroid use--hope for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Multisubstance use as a feature of addiction to anabolic-androgenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Testosterone prohormone supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Human growth hormone doping in sport

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Amphetamine-induced aggression is enhanced in rats pre-treated with the anabolic androgenic steroid nandrolone decanoate

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Anabolic steroid-induced hypogonadism--towards a unified hypothesis of anabolic steroid action

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Cardiac effects of anabolic steroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

The effect of anabolic steroids on the gastrointestinal system, kidneys, and adrenal glands

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Hepatocellular carcinoma associated with recreational anabolic steroid use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Canadian Society for the Study of the Aging Male: response to health Canada's position paper on testosterone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Behavioural manifestations of anabolic steroid use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Psychiatric complications of anabolic steroid abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

21 January 2018

Androgens and the brain

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Behavioral and physiological responses to anabolic-androgenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Testosterone supplementation for depressed men: current research and suggested treatment guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Testosterone and cognitive function: current clinical evidence of a relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Thinking with your gonads: testosterone and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Effects of androgens and estradiol on spine synapse formation in the prefrontal cortex of normal and testicular feminization mutant male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Testosterone and dihydrotestosterone, but not estradiol, enhance survival of new hippocampal neurons in adult male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Violent crime and substance abuse: a medico-legal comparison between deceased users of anabolic androgenic steroids and abusers of illicit drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Psychological and behavioural effects of endogenous testosterone and anabolic-androgenic steroids. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Sudden unexpected death in a female fitness athlete, with a possible connection to the use of anabolic androgenic steroids (AAS) and ephedrine

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Anabolic-androgenic steroid dependence? Insights from animals and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Androgen dependence in hamsters: overdose, tolerance, and potential opioidergic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Anabolic steroids: a fatal attraction?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Altered extracellular levels of DOPAC and HVA in the rat nucleus accumbens shell in response to sub-chronic nandrolone administration and a subsequent amphetamine challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Exercise dependence, social physique anxiety, and social support in experienced and inexperienced bodybuilders and weightlifters

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Medical aspects of sports: epidemiology of injuries, preparticipation physical examination, and drugs in sports

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

A conceptual model of factors contributing to the development of muscle dysmorphia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Eating disorders in the male athlete

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

The relationship between anabolic androgenic steroids and muscle dysmorphia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Hypertension, sports supplements and motivational interviewing

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

An Evaluation of Anabolic-Androgenic Steroid Abusers Over a Period of 1 Year: Seven Case Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

Anabolic Androgenic Steroids and Suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.12.1751

21 January 2018

Identifiers

DOI

10.3810/PSM.2009.12.1751

1 reference

release_32ua3dzfizctzjnb2cfnftquzi

21 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/32ua3dzfizctzjnb2cfnftquzi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference